Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04051632 · ClinicalTrials.gov registry record
Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 96
- Enrollment target
NCT04051632 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 96 participants.
The verdict
NCT04051632 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
Observational study of patients at Boston Childrens Hospital with type 1 diabetes (T1D) who elected to treat their diabetes with the Medtronic 670 G hybrid closed loop insulin pump.
Interventions
- DEVICE Medtronic 670G insulin pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2019-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04051632
The ClinicalTrials.gov registry entry for NCT04051632 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic 670G insulin pump is the first listed.
NCT04051632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04051632 about?
NCT04051632 is a clinical study titled "Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)". Observational study of patients at Boston Childrens Hospital with type 1 diabetes (T1D) who elected to treat their diabetes with the Medtronic 670 G hybrid closed loop insulin pump.
What is the current status of trial NCT04051632?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2018-06-13. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT04051632?
The interventions under investigation include: Medtronic 670G insulin pump (DEVICE).
Who is sponsoring clinical trial NCT04051632?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.